Stocktoria
KESTRA MEDICAL TECHNOLOGIES, LTD. KMTS
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · IPO 2025-03-06
Chart by TradingView
5/9
Piotroski F — financial health
-0.94
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 |
|---|---|---|
| Financials | ||
| Revenue | $59.8M | $27.8M |
| Gross profit | $24.2M | $362,000 |
| Operating income | -$106.4M | -$85.1M |
| Net income | -$113.8M | -$94.1M |
| Operating cash flow | -$77.6M | -$72.2M |
| Free cash flow | -$100.5M | -$84.5M |
| Total assets | $295.7M | $45.9M |
| Total liabilities | $90.3M | $78.2M |
| Shareholders' equity | $205.4M | -$209.4M |
| Ratios | ||
| Gross margin | 40.5% | 1.3% |
| Operating margin | -177.8% | -305.8% |
| Net margin | -190.3% | -338.4% |
| FCF margin | -168.1% | -303.7% |
| Return on assets | -38.5% | -204.8% |
| Return on equity | -55.4% | 45.0% |
| Debt / equity | 0.20× | -0.20× |
| Current ratio | 6.72 | 0.45 |
| Revenue growth | 115.1% | — |
Why these scores methodology →
Piotroski F-score: 5/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -0.94 (distress)
- Working capital / assets 0.735
- Retained earnings / assets -1.759
- EBIT / assets -0.36
- Equity / liabilities 2.274
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001877184 · as of 2025-04-30. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.